home email us! sindicaci;ón

Blog Contributors

Malorye Allison is a contributing editor for the World Health Care Blog, editor-in-chief of Cambridge Healthtech Institute (CHI)’s electronic newsletters PharmaWeek and Biomarker Breakthroughs. She was formerly editor-in-chief of CHI’s PharmaDD magazine and senior informatics editor at IDG’s Bio-ITWorld magazine, where she won the 2003 Neal award for Best Article Series and the Gold Medal Eastern Regional and National awards from the American Society of Business Publication Editors. She developed and launched CHI’s Advances Reports series, which analyzes the scientific and business potential of drug discovery and development technologies and approaches. She was also formerly vice president and director of Decision Resources’ Spectrum Life Sciences unit. Ms. Branca has written numerous articles and analytical reports on a wide range of topics related to drug discovery and development, pharmaceutical strategy, innovation, and health care policy. Her work has appeared in the Harvard Health Letter, Nature Reviews in Drug Discovery, Nature Biotechnology, Patient Care, Science, Start-Up, and The Los Angeles Times.

Lloyd Davis is one of Britain’s foremost social media specialists who has spent 15 years working at the point where people meet technology. Having trained both as an actor and as a software engineer, he brings a unique perspective to the social uses of computing. Lloyd’s keen understanding of how people best use social software was developed during his eight years grappling with Knowledge & Information Management at the UK’s Audit Commission, and through a stint as Head of Knowledge Management at the Commission for Patient & Public Involvement in Health. Creating his first blog in 2002, Lloyd launched perfectpath.co.uk in 2004. At the end of that year, he became one of London’s very first podcasters and videobloggers, finishing 2005 with an award nomination for “Best Implementation of a Business Blog”. Lloyd now specializes in blogging and documenting events and conferences using social media.

Tony Chen is Director of New Business Development for Evanston Northwestern Healthcare, where he is responsible for the technology commercialization of the organization’s patent portfolio and the development of new hospital-related services, programs, and innovations. Previously, Tony was Director of Product Innovation at Healthcare Financial Management Association and a project leader at Merck. Tony holds an MBA from the Kellogg School of Management and a BS in Chemical Engineering from Cornell University. His blog, Hospital Impact, is one of the most prominent hospital blogs in the country.

Emily DeVoto is an independent health care consultant, epidemiologist, and writer. A former senior editor at the Journal of the National Cancer Institute, Emily has also designed and led an innovative course for health journalists at the National Institutes of Health on evaluating clinical research. She is committed to improving the quality and efficiency of health care delivery and blogs at The Antidote.

Alfred J. Fortin, Ph.D., is a Senior Vice President for the Blue Cross Blue Shield Plan of Hawaii and has worked in health care for over 35 years. Fred oversees strategic policy development, legal affairs and related areas for the Blue plan, the largest health plan in Hawaii. He has also served as the Plan’s Vice President, Office of Policy and Planning and Vice President of Community Relations. These positions involved broad oversight of community and government relations, and media communications. In addition, Fred has an extensive background in health and human services, ranging from mental health crisis intervention, to child abuse prevention, to research on AIDS in Africa. He was the recipient of a national fellowship from the American Council of Learned Societies in 1986 to study AIDS in Kenya. From 1989 to 1991 Fred was an assistant professor of psychiatry at the University of Hawaii ’s John A. Burns School of Medicine and an adjunct professor at the School of Public Health at the University of Hawaii. Fred earned his bachelor’s degree in political science from the University of Massachusetts, a master’s degree in clinical social work from the University of Connecticut and a doctorate in health politics from the University of Hawaii. He blogs regularly at www.ajfortin.com.

Matthew Holt has more than 15 years experience as a researcher, forecaster and strategy consultant in the healthcare industry. Before launching his own consulting practice, Matthew was the VP of Strategy and Business Development at i-Beacon, an eHealth company. Previously he worked at Harris Interactive, the leading healthcare survey company, and before that led the healthcare IT practice at the forecasting organization Institute for the Future. His blog, called a “must-read” by the Wall Street Journal: The Health Care Blog.

Nick Jacobs is president of Windber Medical Center and the Windber Research Institute, a translational medicine proteomic and genomic research institute which focuses on heart, breast and reproductive diseases. Before being named to his current positions, Mr. Jacobs served as the Chief Communications Officer of the Conemaugh Health System; Executive Director for the Conemaugh Health Foundation; Vice President of Mercy Medical Center; Executive Director of the Mercy Healthcare Foundation, President of the Laurel Highlands Convention and Visitors Bureau; Executive Director of Laurel Arts of Somerset, PA; Teacher and Department Chair for Westmont and Johnstown Schools; for the Plum Borough School District in Pittsburgh; and was a professional trumpet player. He holds a Master’s degree in Public Management/Health Systems Management from Carnegie Mellon University, and Master’s and Bachelor’s degrees in Education from Indiana University of Pennsylvania. He serves on numerous board, has received various professional awards, and his writings have appeared in many national healthcare magazines.

Vince Kuraitis, JD, MBA, is Principal and founder of Better Health Technologies, LLC, and blogs here. BHT consults to companies in developing strategy, partnerships and business models for chronic disease management and eHealth applications delivered in homes, workplaces, and communities. BHT’s clients are both established organizations and early-stage companies, including: Intel Digital Health Group, Philips Electronics, Joslin Diabetes Center, Samsung Electronics, Siemens Medical Solutions, Medtronic, Varian Medical Systems, Disease Management Association of America, and many others. Vince brings 23 years health care experience in multiple roles: President, VP Corporate Development, VP operations, management consultant, and marketing executive. His consulting and work projects span 100+ different health care organizations, including hospitals, physician groups, medical devices, pharma, health plans, disease management, e-Health, IT, and others. Vince speaks frequently at industry conferences and corporate events.

Derek Lowe got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He hasworked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer’s, diabetes, osteoporosis and other diseases. His blog has been named a best blog by Forbes and other publications and he is frequently interviewed by the business and industry press on pharma research. His blog: In the Pipeline.

Scott MacStravic, Ph.D., is semi-retired after a 35-year career as a hospital and health system executive, a professor and consultant on hospital planning, healthcare marketing and PHM. He is the author of 10 books and more than 500 articles on these subjects.

Gary Schwitzer has specialized in health care journalism for more than 30 years. He is an Associate Professor in the School of Journalism and Mass Communication at the University of Minnesota, and is director of graduate studies for the School’s Health Journalism graduate program. He is Publisher of the website - www.HealthNewsReview.org - to support excellence in health and medical journalism.  In its first year it won a Knight-Batten Award for Innovations in Journalism, an e-HealthCare Leadership Award, and a Mirror Award for excellence in media industry reporting. Earlier in his career, Schwitzer was the founding Editor-In-Chief of the MayoClinic.com consumer health web site. He worked in television medical news for 15 years – at CNN in Atlanta, WFAA-TV in Dallas, and WTMJ-TV in Milwaukee. He was a two-term member of the board of directors of the Association of Health Care Journalists, for whom he authored a journalists’ Statement of Principles.

David Williams, who blogs regularly at the Health Business Blog, is the co-founder of health care strategy firm MedPharma Partners, serving clients in technology-enabled health care services, pharmaceuticals, biotech, medical devices, and medical software. Before co-founding MedPharma Partners he worked for ten years in the health care practice of the Boston Consulting Group and as an independent consultant. Earlier he was a strategy consultant at the LEK Partnership. David holds a BA in Economics from Wesleyan University, where he was elected to Phi Beta Kappa, and an MBA from Harvard Business School, with First Year Honors. He is Chairman of the Board of medical risk management company Advanced Practice Strategies and also serves on the boards of ECG biomarker company iCardiac Technologies and the Hearts and Noses Hospital Clown Troupe, which provides professionally trained volunteer clowns to children facing serious illnesses.

2 Comments »

  junesix : Bloggers at the WHHC wrote @ April 21st, 2007 at 10:39 pm

[…] to have caught on over at the World Health Care Congress conference. WHHC gathered some of the top bloggers in the healthcare world to contribute and I’ve been impressed with the frequency and quality […]

  Nishant wrote @ June 13th, 2007 at 8:39 pm

I am trying to understand the difference between monoclonal antibodies in different animal models: rats, mouse, rabbit.
- What is the difference between the different animal models? Are they interchangeable? How is one picked over the other?
- Which animal models are used most widely? What are its shortcomings and what new models are being developed?
- What are the advantages/disadvantages of rabbit monoclonal antibodies? Are they likely to be used widely in the future? (Epitomics www.epitomics.com/ supplies these antibodies)

Thanks for your help,
Nishant

Your comment

HTML-Tags:
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>